Showing results (1-10 of 714) with videos related to
Sort By:
Pageof 72
Current Atherosclerosis Reports|March 13, 2012
Myeloperoxidase production by macrophage and risk of atherosclerosisMahir Karakas, Wolfgang KoenigPharmaceuticals (Basel, Switzerland)|October 8, 2016
Lp-PLA2 Inhibition-The Atherosclerosis Panacea?Mahir Karakas, Wolfgang KoenigIdrugs : the Investigational Drugs Journal|August 22, 2009
Varespladib methyl, an oral phospholipase A2 inhibitor for the potential treatment of coronary artery diseaseMahir Karakas, Wolfgang KoenigThrombosis and Haemostasis|March 9, 2012
Variability of fibrinogen measurements in post-myocardial infarction patients. Results from the AIRGENE study center AugsburgJens Baumert, Mahir Karakas, Sonja Greven, et al.Clinical Chemistry|March 20, 2010
Reproducibility in serial C-reactive protein and interleukin-6 measurements in post-myocardial infarction patients: results from the AIRGENE studyMahir Karakas, Jens Baumert, Sonja Greven, et al.Clinical Chemistry|August 21, 2014
Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 yearsMahir Karakas, Andrea Jaensch, Lutz P Breitling, et al.Plos One|September 15, 2015
Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve RegurgitationJochen Wöhrle, Mahir Karakas, Ulrike Trepte, et al.BMC Public Health|May 12, 2012
Prevalence and determinants of chronic kidney disease in community-dwelling elderly by various estimating equationsDietrich Rothenbacher, Jochen Klenk, Michael Denkinger, et al.Atherosclerosis|September 8, 2009
Leptin, adiponectin, their ratio and risk of Coronary Heart Disease: results from the MONICA/KORA Augsburg Study 1984-2002Mahir Karakas, Astrid Zierer, Christian Herder, et al.Pageof 72